MONTREAL, Aug. 24, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today the closing of a non-brokered $2.5 million private placement of units (the “Private Placement“). “We are thankful, once again, for the continued financial support from our …